Table of Contents

Global Parkinson’s Disease Treatment Market Growth (Status and Outlook) 2019-2024

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Parkinson’s Disease Treatment Market Size 2014-2024
  • 2.1.2 Parkinson’s Disease Treatment Market Size CAGR by Region
• 2.2 Parkinson’s Disease Treatment Segment by Type
  • 2.2.1 Oral
  • 2.2.2 Oral
  • 2.2.3 Subcutaneous
  • 2.2.4 Intestinal Infusion
• 2.3 Parkinson’s Disease Treatment Market Size by Type
  • 2.3.1 Global Parkinson’s Disease Treatment Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Parkinson’s Disease Treatment Market Size Growth Rate by Type (2014-2019)
• 2.4 Parkinson’s Disease Treatment Segment by Application
  • 2.4.1 Hospital Pharmacy
  • 2.4.2 Retail Pharmacy
  • 2.4.3 Online Pharmacy
• 2.5 Parkinson’s Disease Treatment Market Size by Application
  • 2.5.1 Global Parkinson’s Disease Treatment Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Parkinson’s Disease Treatment Market Size Growth Rate by Application (2014-2019)

3 Global Parkinson’s Disease Treatment by Players

• 3.1 Global Parkinson’s Disease Treatment Market Size Market Share by Players
  • 3.1.1 Global Parkinson’s Disease Treatment Market Size by Players (2017-2019)
  • 3.1.2 Global Parkinson’s Disease Treatment Market Size Market Share by Players (2017-2019)
• 3.2 Global Parkinson’s Disease Treatment Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Parkinson’s Disease Treatment by Regions

• 4.1 Parkinson’s Disease Treatment Market Size by Regions
• 4.2 Americas Parkinson’s Disease Treatment Market Size Growth
• 4.3 APAC Parkinson’s Disease Treatment Market Size Growth
• 4.4 Europe Parkinson’s Disease Treatment Market Size Growth
• 4.5 Middle East & Africa Parkinson’s Disease Treatment Market Size Growth

5 Americas

• 5.1 Americas Parkinson’s Disease Treatment Market Size by Countries
• 5.2 Americas Parkinson’s Disease Treatment Market Size by Type
• 5.3 Americas Parkinson’s Disease Treatment Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Parkinson’s Disease Treatment Market Size by Countries
• 6.2 APAC Parkinson’s Disease Treatment Market Size by Type
• 6.3 APAC Parkinson’s Disease Treatment Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Parkinson’s Disease Treatment by Countries
• 7.2 Europe Parkinson’s Disease Treatment Market Size by Type
• 7.3 Europe Parkinson’s Disease Treatment Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Parkinson’s Disease Treatment by Countries
• 8.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type
• 8.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Parkinson’s Disease Treatment Market Forecast

• 10.1 Global Parkinson’s Disease Treatment Market Size Forecast (2019-2024)
• 10.2 Global Parkinson’s Disease Treatment Forecast by Regions
  • 10.2.1 Global Parkinson’s Disease Treatment Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Parkinson’s Disease Treatment Forecast by Type
• 10.8 Global Parkinson’s Disease Treatment Forecast by Application

11 Key Players Analysis

• 11.1 Acorda Therapeutics
  • 11.1.1 Company Details
  • 11.1.2 Parkinson’s Disease Treatment Product Offered
  • 11.1.3 Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Acorda Therapeutics News
• 11.2 Orion Pharmaceuticals
  • 11.2.1 Company Details
  • 11.2.2 Parkinson’s Disease Treatment Product Offered
  • 11.2.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Orion Pharmaceuticals News
• 11.3 Roche
  • 11.3.1 Company Details
  • 11.3.2 Parkinson’s Disease Treatment Product Offered
  • 11.3.3 Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Roche News
• 11.4 Teva
  • 11.4.1 Company Details
  • 11.4.2 Parkinson’s Disease Treatment Product Offered
  • 11.4.3 Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Teva News
• 11.5 Voyager Therapeutics
  • 11.5.1 Company Details
  • 11.5.2 Parkinson’s Disease Treatment Product Offered
  • 11.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Voyager Therapeutics News
• 11.6 Prothena
  • 11.6.1 Company Details
  • 11.6.2 Parkinson’s Disease Treatment Product Offered
  • 11.6.3 Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Prothena News
• 11.7 AbbVie
  • 11.7.1 Company Details
  • 11.7.2 Parkinson’s Disease Treatment Product Offered
  • 11.7.3 AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 AbbVie News
• 11.8 Impax Pharmaceuticals
  • 11.8.1 Company Details
  • 11.8.2 Parkinson’s Disease Treatment Product Offered
  • 11.8.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.8.4 Main Business Overview
  • 11.8.5 Impax Pharmaceuticals News
• 11.9 MSD
  • 11.9.1 Company Details
  • 11.9.2 Parkinson’s Disease Treatment Product Offered
  • 11.9.3 MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.9.4 Main Business Overview
  • 11.9.5 MSD News
• 11.10 UCB
  • 11.10.1 Company Details
  • 11.10.2 Parkinson’s Disease Treatment Product Offered
  • 11.10.3 UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.10.4 Main Business Overview
  • 11.10.5 UCB News
• 11.11 GSK
• 11.12 Intec Pharma
• 11.13 Acadia
• 11.14 Adamas Therapeutics
• 11.15 Sunovion
• 11.16 NeuroDerm

12 Research Findings and Conclusion

According to this study, over the next five years the Parkinson’s Disease Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Parkinson’s Disease Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Parkinson’s Disease Treatment market by product type, application, key companies and key regions.

This study considers the Parkinson’s Disease Treatment value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Oral
Transdermal
Subcutaneous
Intestinal Infusion

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Acorda Therapeutics
Orion Pharmaceuticals
Roche
Teva
Voyager Therapeutics
Prothena
AbbVie
Impax Pharmaceuticals
MSD
UCB
GSK
Intec Pharma
Acadia
Adamas Therapeutics
Sunovion
NeuroDerm

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Parkinson’s Disease Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Parkinson’s Disease Treatment market by identifying its various subsegments.
Focuses on the key global Parkinson’s Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Parkinson’s Disease Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Parkinson’s Disease Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.